Mint Tower Capital Management B.V. Regeneron Pharmaceuticals, Inc. Transaction History

Mint Tower Capital Management B.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$595.12 - $698.43 $35,112 - $41,207	-59 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$543.48 - $670.97 $32,065 - $39,587	59 New	59 $37,000
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $1.32 Million - $1.54 Million	-4,838 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $1.4 Million - $1.94 Million	4,670 Added 2779.76%	4,838 $0
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $62,509 - $73,847	168 New	168 $69,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

Stay updated on Mint Tower Capital Management B.V. with notifications on news.